Journal article

Flibanserin: a potential treatment for Hypoactive Sexual Desire Disorder in premenopausal women.

AH Clayton, L Dennerstein, R Pyke, M Sand

Women's Health | Published : 2010


Hypoactive Sexual Desire Disorder (HSDD) is defined as a persistent or recurrent deficiency of sexual fantasies and desire for sexual activity, which causes marked personal distress or interpersonal difficulty, and is not better accounted for by another psychiatric disorder or the direct physiological effects of a substance (e.g., a medication) or medical condition. HSDD is believed to be the most common form of Female Sexual Dysfunction and is associated with emotional distress and relationship problems. No pharmacologic therapy is approved for the treatment of HSDD in premenopausal or naturally postmenopausal women. Flibanserin is a 5-HT(1A) agonist/5-HT(2A) antagonist that is under invest..

View full abstract

University of Melbourne Researchers